ESR1 and breast cancer: Further analyses of the prognostic values of these genes in ER+ BC, at both transcriptomic and protein levels, showed that four biomarkers (PR, GREB1, AR and BEX1) maintained their prognostic significance, with only two genes (PR and GREB1) maintaining their independent prognostic significance in ER+ BC patients who received ET.